Becker David Paul 4
4 · PERNIX THERAPEUTICS HOLDINGS, INC. · Filed Dec 14, 2012
Insider Transaction Report
Form 4
Becker David Paul
Chief Financial Officer
Transactions
- Disposition to Issuer
Options (right to buy)
2012-12-07−150,000→ 0 totalExercise: $8.20Exp: 2021-12-05→ common stock (150,000 underlying) - Award
Common Stock
2012-12-07+200,000→ 200,000 total
Footnotes (3)
- [F1]Represents a grant of restricted stock from the Company that vests in 1/3 annual increments beginning on December 7, 2013 and ending on the second anniversary thereof.
- [F2]The option was originally granted on 12/5/11 and was to vest in 1/3 increments beginning on 12/5/12 and ending on the second anniversary thereof.
- [F3]The option was cancelled by mutual agreement of the reporting person and the Company. As consideration for the cancellation, the reporting person received 50,000 restricted shares which are included in the grant reported above in Table I.